Clinuvel Pharmaceuticals Ltd
ASX:CUV

Watchlist Manager
Clinuvel Pharmaceuticals Ltd Logo
Clinuvel Pharmaceuticals Ltd
ASX:CUV
Watchlist
Price: 15.26 AUD 1.19% Market Closed
Updated: May 17, 2024

EV/S
Enterprise Value to Sales

6.8
Current
12.1
Median
7.5
Industry
Lower than median
Lower than industry value

Enterprise Value to Sales (EV/S) ratio is a valuation multiple that compares the enterprise value (EV) of a company to its revenues. The EV/S multiple gives investors a quantifiable metric of how to value a company based on its sales while taking account of both the company's equity and debt.

EV/S
6.8
=
Enterprise Value
591.2m
/
Revenue
87.3m
All Countries
Close

EV/S Forward Multiples

Forward EV/S multiple is a version of the EV/S ratio that uses forecasted revenue for the EV/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/S
hidden
2-Years Forward
EV/S
hidden
3-Years Forward
EV/S
hidden

See Also

Discover More